Nohla Therapeutics

Nohla Therapeutics is a cell therapy company dedicated to providing leading off-the-shelf therapies for critically ill patients. Nohla's first product is a universal donor cell therapy targeting hematopoietic recovery and chemotherapy-induced neutropenia, and it is expanding to address a variety of other medical indications. This product, along with others in development, is based on a unique cord blood expansion platform developed by the Fred Hutchinson Cancer Research Center.